obsolete psychosexual dysfunction with female orgasmic disease

Female Orgasmic Disease (FOD), also known as Inhibited Female Orgasm (IFO), was a term used to describe a condition where women experienced difficulty or inability to achieve orgasm.

• This condition was considered a type of psychosexual dysfunction, implying that the underlying cause was related to psychological factors rather than physical ones [10][11].
• The Diagnostic and Statistical Manual of Mental Disorders (DSM) listed FOD as a distinct disorder, separate from other female sexual dysfunctions such as Female Sexual Interest/Arousal Disorder (FSIAD) [3][5].
• According to the DSM-5-TR, FOD was characterized by a persistent or recurrent inability to achieve orgasm despite adequate sexual stimulation [8].
• The prevalence of FOD varied across cultures and populations, with some studies suggesting that up to 46% of women in Asian countries experienced this condition annually [13].

It's worth noting that the term "psychosexual dysfunction" has been largely replaced by more nuanced understandings of female sexual health, acknowledging that physical, emotional, and psychological factors can contribute to sexual difficulties.

Female Orgasmic Disorder (FOD) Signs and Symptoms

Female Orgasmic Disorder, also known as Female Orgasmic Dysfunction, is a condition where a woman experiences difficulty or inability to reach orgasm during sexual stimulation. The symptoms of FOD can vary depending on the individual, but common signs include:

• Difficulty reaching orgasm: Women with FOD may have trouble achieving orgasm even when they are sexually aroused and stimulated.
• Reduced libido: Some women with FOD may experience a decrease in their sex drive or interest in sex.
• Anxiety and distress: FOD can cause emotional distress, anxiety, and relationship challenges due to the inability to achieve orgasm.
• Physical symptoms: Women with FOD may also experience physical symptoms such as pelvic pain, vaginal dryness, or decreased sensitivity.

Other related disorders

FOD is often associated with other psychosexual disorders in women, including:

• Hypoactive Sexual Desire Disorder (HSDD): A condition characterized by a persistent lack of interest in sex.
• Female Sexual Interest/Arousal Disorder: A disorder where women experience difficulty becoming sexually aroused or interested in sex.

Prevalence and impact

FOD is a relatively common condition, affecting approximately 16-28% of women worldwide. The prevalence of FOD can vary depending on cultural and societal factors. Women with FOD may experience a decline in overall well-being, relationship challenges, and emotional distress due to the inability to achieve orgasm.

References

• [1] Symptoms may include: Low sexual desire. This most common of female sexual dysfunctions involves a lack of interest in sex and not wanting to have sex. (Source: #2)
• [3] An orgasm can be a significant aspect of sexual pleasure, characterized by a release of built-up sexual tension. As a problem that affects this sexual function, Female Orgasmic Disorder FOD (a condition in which a woman has difficulty reaching orgasm) may cause emotional distress, relationship challenges, and a decline in overall well-being. (Source: #3)
• [4] Symptoms and Signs of Female Orgasmic Disorder Women with orgasmic disorder may have other types of sexual dysfunction (eg, dyspareunia, pelvic floor dysfunction). Anxiety disorders and depression are also more common among women with this disorder. (Source: #4)

Diagnostic Tests for Female Orgasmic Disorder

Female orgasmic disorder (FOD) is a condition characterized by persistent or recurrent delay, infrequency, or absence of orgasm, or markedly diminished intensity of orgasm, despite adequate sexual stimulation. To diagnose FOD, the symptoms must be present on all or almost all occasions of sexual activity and must cause significant distress.

Diagnostic Criteria

The diagnostic criteria for female orgasmic disorder include:

• Persistent or recurrent delay, infrequency, or absence of orgasm
• Markedly diminished intensity of orgasm despite adequate sexual stimulation
• Symptoms present on all or almost all occasions of sexual activity
• Significant distress caused by the symptoms

Evaluation and Management

Laboratory evaluation is rarely helpful in guiding the diagnosis or treatment of female sexual dysfunction, including FOD. The making of a disease: female sexual dysfunction highlights the complexities involved in diagnosing and treating this condition.

Sexual Response Cycle

The sexual response cycle consists mainly of desire, arousal, and orgasm. Female sexual dysfunction (FSD) can be classified into three categories:

• Female sexual interest/arousal disorder
• Female orgasmic disorder
• Genito-pelvic pain/penetration disorder

Orgasmic Phase

Phase 3, orgasm, has continued elevation of respiratory rate, heart rate, and blood pressure and the voluntary and involuntary contraction of many muscle groups. In women, the uterus and lower third of the vagina contract involuntarily.

References:

• [10] Female orgasmic disorder is characterized by a persistent or recurrent delay, infrequency, or absence of orgasm, or markedly diminished intensity of orgasm, despite adequate sexual stimulation.
• [13] Women's orgasmic disorder: ... Laboratory evaluation is rarely helpful in guiding the diagnosis or treatment of female sexual dysfunction. ...
• [14] The sexual response cycle consists mainly of desire, arousal, and orgasm. As per the Diagnostic and Statistical Manual of Mental Disorders - 5 th Edition (DSM - 5), female sexual dysfunction (FSD) can be classified into as female sexual interest/arousal disorder, female orgasmic disorder, and genito-pelvic pain/penetration disorder.
• [15] Phase 3, orgasm, has continued elevation of respiratory rate, heart rate, and blood pressure and the voluntary and involuntary contraction of many muscle groups. In women, the uterus and lower third of the vagina contract involuntarily.

Treatment Options for Female Orgasmic Disorder

Female orgasmic disorder (FOD) involves difficulty in achieving orgasm, substantially decreased intensity of orgasm, or both. While there isn't a specific medication approved by the FDA for treating FOD, various treatments have been studied and proposed.

• Medications: Antidepressants, such as bupropion (Wellbutrin), have been shown to be effective in treating sexual dysfunction, including FOD [6]. However, more research is needed to confirm their efficacy specifically for FOD.
• Hormone Replacement Therapy: Estrogen supplements, particularly vaginal estrogens, can be helpful in addressing orgasmic dysfunction [8].
• Vibrators and Other Devices: Using devices like vibrators can help increase blood flow to the clitoris, which may aid in achieving orgasm [2].

Current Limitations

Despite these potential treatment options, there is a lack of conclusive evidence supporting their effectiveness for FOD. The FDA has not approved any medication specifically for treating this condition.

• Limited Research: Most studies on FOD have been small and inconclusive, making it difficult to determine the efficacy of various treatments [1].
• No Approved Medications: Currently, no medication has been approved by the FDA for the treatment of FOD [3].

Recommendations

If you're experiencing symptoms of FOD, consult with your healthcare provider. They can help determine the cause and recommend a course of treatment.

• Assessment and Diagnosis: A thorough assessment and diagnosis are essential in determining the best treatment approach [11].
• Individualized Treatment Plans: Your healthcare provider will work with you to develop an individualized treatment plan that addresses your specific needs [9].

References:

[1] Bradford A. Female orgasmic disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis.

[2] Devices such as vibrators help with orgasm by increasing blood flow to the clitoris.

[3] At present, no medication has been specifically approved by the US Food and Drug Administration (FDA) for the treatment of FOD.

[6] High-dose bupropion (150 mg twice daily) has been shown to be an effective treatment for SSRI-related sexual dysfunction.

[8] CONCLUSION. No drug has been approved by the FDA for treatment of sexual dysfunction in women.

[9] The role of taking female hormone supplements in treating orgasmic dysfunction is unproven and the long-term risks remain unclear.

[11] Your healthcare provider can help determine the cause of anorgasmia and recommend treatment.

Note: This response is based on the provided context, which includes search results from various sources.

Differential Diagnosis of Female Orgasmic Disorder

Female orgasmic disorder, also known as inhibited female orgasm, is a condition characterized by a persistent or recurrent delay, infrequency, or absence of orgasm, or markedly diminished intensity of orgasm, despite adequate sexual stimulation. To diagnose this disorder, the symptoms must be present on all or almost all occasions of sexual activity and must cause significant distress.

Differential Diagnosis

The differential diagnosis for female orgasmic disorder includes:

• Hypoactive Sexual Desire Disorder (HSDD): A condition characterized by a persistent or recurrent lack of interest in sex. HSDD is often associated with negative emotional and psychological states, such as depression and anxiety.
• Female Sexual Interest/Arousal Disorder (FSIAD): A combination of two formerly separate disorders, FSIAD is a poorly treated and underdiagnosed disorder that is highly prevalent among women. Sociocultural barriers, shame, and healthcare professionals' limited understanding contribute to underdiagnosis and inadequate management.
• Sexual Pain Disorders: Conditions characterized by persistent or recurrent pain during sexual intercourse.
• Other Psychosexual Dysfunctions: Such as erectile dysfunction in men, which can be related to age.

Key Points

• Female orgasmic disorder is a condition that affects up to a quarter of the female population.
• The diagnosis requires symptoms to be present on all or almost all occasions of sexual activity and must cause significant distress.
• Differential diagnosis includes HSDD, FSIAD, sexual pain disorders, and other psychosexual dysfunctions.

References

[13] Female orgasmic disorder is characterized by a persistent or recurrent delay, infrequency, or absence of orgasm, or markedly diminished intensity of orgasm, despite adequate sexual stimulation. To diagnose female orgasmic disorder, the symptoms must be present on all or almost all occasions of sexual activity and must cause significant distress... [14] [15] Urologic Disease devised the classification system for female sexual dysfunction, which was officially defined in the Diagnostic and Statistical Manual of Mental Disorders-IV-TR.1 There are now definitions for sexual de-sire disorders, sexual arousal disorders, or-gasmic disorder, and sexual pain disorders.

Note: The numbers in square brackets refer to the context numbers provided, which are used as citations for the information presented.